TrialX Partners with The Michael J. Fox Foundation to Power Its Parkinson’s Clinical Trial Finder
We are excited to share that our enterprise recruitment platform was selected by the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to power the Fox Trial Finder, a critical tool for the Parkinson’s community to access and navigate clinical trial information. Individuals interested in participating in research can now search eligible studies based on location and health history. They can also sign up to receive updates from The Michael J. Fox Foundation and emails regarding future studies they may be eligible for. “Through our partnership with TrialX, Fox Trial Finder connects participants with the right studies for them, speeding trial recruitment and thereby the findings that will drive toward new therapies and better quality of life for the Parkinson’s community.” said Maggie Kuhl, MJFF Vice President of Research Engagement…Read More.
What’s new at TrialX?
📢PRODUCT UPDATES
The Axiom Mission 3 (Ax-3) launched January 18, 2024! In partnership with the Translational Research Institute for Space Health (TRISH) we are excited to support yet another space mission with the EXPAND mobile App that collects and stores pre-flight, in-flight and post-flight health research data from commercial astronauts during space missions. Ax-3 is the third commercial astronaut mission to the ISS and the crew will live and work aboard the ISS for up to 14 days. TRISH will conduct a suite of human health and performance research projects during this first all-European commercial astronaut mission. Read More.
🤝CONFERENCE
SCOPE 2024 is coming up in February and our Chief Strategy Officer, Paul Donnelly is all ready to share about our enterprise recruitment platform and the remote data collection platform with industry leaders from pharma, CROs, investigator sites, and advocacy groups including investors and other stakeholders. Schedule a meet with Paul here.
RECENT CURETALKS
Lecithin cholesterol acyltransferase (LCAT) deficiency is a genetic disorder that affects the body’s ability to process cholesterol. Fewer than 1000 people in the US have this disease which is characterized by corneal opacity, hemolytic anemia and kidney failure. In our recent CureTalks episode watch patient advocates Jason and Beverley talk to Dr. Marina Cuchel from University of Pennsylvania to understand the condition better. Watch here.
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
PILOT STUDY: EPIGENETICS AND AUTISM SPECTRUM DISORDER: Did You Know? The number of children developing autism in the US is increasing and about 1 in 45 children are diagnosed. Learn more.
My Lungs have a pH? pH is a measurement of acidity. Lung pH, or airway pH, is the measurement of acidity in the lungs and airway specifically. Airway pH varies from person to person, depending on their health. Because of this, IU School of Medicine is collecting an airway pH spectrum from a variety of people with and without lung disease. Learn more.
HeartShare: The overall goal of the HeartShare Deep Phenotyping Study is to create a rich repository of data (e.g., demographic, social determinants of health, clinical, physiological, laboratory), images, and multi-omics (blood and tissue samples) that will serve as a resource for investigators to identify novel HFpEF subtypes and mechanisms (biological and pathophysiological) to inform future strategies for enhanced diagnosis and treatment of HFpEF. Learn more.
🌎 AROUND THE WEB
🧑🚀️ The Ax-3 crew settles in on the ISS! Daily Updates.
🔭 Reflect on this! NASA moon orbiter beams laser off Indian lander in historic 1st.
🚀 Japan’s Stout Spacecraft Just Made Moon History!
🫂 Patient Engagement Needs More Benefit Analysis, Fewer Theoretical Conversations.
🌼 What almost dying taught me about living? Shares patient advocate Suleika Jaouad.
🌞 An exceptional solar eclipse coming up!
✌TEAM UPDATES
As an ongoing tradition we organized another year end Hackathon closing out 2023. We called it Surge-athon 2023 where the participants had to learn and create something new in just few days of intense surge. The theme was Regenerative AI and the participants came up with cool prototypes related to applications of AI in driving efficiencies across clinical trials processes.
We look forward to further our contribution towards bridging gaps in clinical research here on earth and in space. Stay tuned for more updates as we continue to look up to the moon!
All the best,
Team TrialX
